Hospital Acquired Infection Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Surgical Volumes and ICU Admissions
  • 4.2.2 Mandatory Reporting of HAIs in U.S. & Select EU Nations
  • 4.2.3 Rise in the Incidences of Different Types of Hospital Acquired Infections
  • 4.2.4 Innovative Technologies Implemented in Devices that Control Infection
  • 4.2.5 Rapid Expansion of Ambulatory Surgery Centers in North America
  • 4.2.6 Growing Adoption of Low-temperature H2O2 Sterilizers in Europe
• 4.3 Market Restraints
  • 4.3.1 Lack of Awareness Regarding Hospital Acquired Infection
  • 4.3.2 Stringent Regulatory Requirement
  • 4.3.3 High Capital Cost of UV/HPV Disinfection Systems for Tier-2 Hospitals
  • 4.3.4 Workforce Skill Gaps in Endoscope Reprocessing
• 4.4 Supply-Chain Analysis
• 4.5 Technological Outlook
• 4.6 Porters Five Forces
  • 4.6.1 Threat of New Entrants
  • 4.6.2 Bargaining Power of Buyers
  • 4.6.3 Bargaining Power of Suppliers
  • 4.6.4 Threat of Substitutes
  • 4.6.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product and Services
  • 5.1.1 By Equipment
    • 5.1.1.1 Sterilization
      • 5.1.1.1.1 Steam Sterilizers
      • 5.1.1.1.2 Low-temperature H₂O₂ Sterilizers
      • 5.1.1.1.3 Ethylene Oxide Sterilizers
      • 5.1.1.1.4 Radiation Sterilization
      • 5.1.1.1.5 Contract Sterilization Services
    • 5.1.1.2 Disinfection
      • 5.1.1.2.1 UV & Hydrogen-Peroxide-Vapor Devices
      • 5.1.1.2.2 Endoscopic Reprocessor Systems
    • 5.1.1.3 Others
  • 5.1.2 Services
  • 5.1.3 Consumables
• 5.2 By End-user
  • 5.2.1 Hospitals & Intensive Care Units (ICUs)
  • 5.2.2 Ambulatory Surgical Centers (ASCs)
  • 5.2.3 Long-term Care Facilities
  • 5.2.4 Specialty Clinics & Dialysis Centers
• 5.3 By Infection Type
  • 5.3.1 Surgical Site Infections (SSI)
  • 5.3.2 Catheter-associated Urinary Tract Infections (CAUTI)
  • 5.3.3 Central-line Associated Bloodstream Infections (CLABSI)
  • 5.3.4 Hospital-acquired & Ventilator-associated Pneumonia (HAP/VAP)
  • 5.3.5 Gastro-intestinal Infections & Others
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Dentsply Sirono
  • 6.3.2 3M Company
  • 6.3.3 Steris PLC
  • 6.3.4 Getinge AB
  • 6.3.5 Ecolab Inc.
  • 6.3.6 Advanced Sterilization Products
  • 6.3.7 Steris
  • 6.3.8 Belimed AG
  • 6.3.9 Becton, Dickinson and Company
  • 6.3.10 Olympus Corporation
  • 6.3.11 Matachana Group
  • 6.3.12 MMM Group
  • 6.3.13 Cardinal Health Inc.
  • 6.3.14 Halyard Health
  • 6.3.15 Ansell Limited
  • 6.3.16 Metrex Research (Envista)
  • 6.3.17 HuFriedyGroup
  • 6.3.18 GAMA Healthcare
  • 6.3.19 Medline Industries
  • 6.3.20 Steelco S.p.A.
  • 6.3.21 Fedegari Autoclavi S.p.A.
  • 6.3.22 Tuttnauer

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment